Anesthetic and Perioperative Risk Assessment Before Programmed Surgery: Anesthetic Teleconsultation Versus Face-to-face Anesthesia Consultation. (TELANESTH)

December 16, 2025 updated by: Centre Hospitalier Universitaire de Nīmes

The anesthesia safety decree made it compulsory in 1994 to carry out a pre-anesthesia consultation before any operative or interventional act. With the inclusion of telemedicine in the Public Health Code then the publication of Addendum 6 in 2018 and finally the derogatory decree in March 2020, it is possible to perform and bill for pre-anesthesia consultation via telemedicine.

The consultation is always followed by a pre-anesthetic visit upon admission of the patient the day before or the day of the operation to verify the information recorded during the consultation and the patient's state of health. This identifies elements omitted during the pre-anesthesia consultation (face-to-face or remotely) and reduces the risks of potential postponement.

The study investigators hypothesize that there would be no difference in the quality of the information given, the collection of medical, paramedical and medication elements and the evaluation of the operative risk in anesthesia consultation via teleconsultation versus face-to-face. The critical points are the medication reconciliation of the patient's treatments, the overall assessment of the operative risk and anticipated difficulty of access to the airways (mouth opening: ≥ or <35 mmm).

Study Overview

Study Type

Interventional

Enrollment (Actual)

172

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Gard
      • Nîmes, Gard, France, 30029
        • Centre Hospitalier Universitaire de Nīmes

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Study Population

Adult patients with outpatient or hospilization programmed surgery requring a unique pre-anesthesia consultation at the CHU Nîmes.

Description

Inclusion Criteria:

  • The patient must have given their free and informed consent and signed the consent form
  • The patient must be a member or beneficiary of a health insurance plan
  • Patient with scheduled surgical intervention (outpatient or hospitalization) at the Nîmes University Hospital requiring a preoperative anesthesia consultation.
  • Patient with computer equipment at home allowing the use of the Téléo software (computer equipment with web cam, audio and microphone or smartphone).

Exclusion Criteria:

  • The subject is participating in a category 1 interventional study, or is in a period of exclusion determined by a previous study
  • The subject refuses to sign the consent
  • It is impossible to give the subject informed information
  • The patient is under safeguard of justice or state guardianship
  • Patient who has already had an anesthesia consultation for surgery within the previous 6 months.
  • Emergency or radiology and / or interventional surgery (eg. gastroscopy, biopsy under scanner, etc.).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Control group
The anesthesia consultation is carried out in person in accordance with the usual management.
Experimental: Teleconsultation
Anesthesia consultation is carried out in teleconsultation via the "Téléo" web application (audio and video) at the patient's home on a computer or smartphone. This application allows sending and receiving documents identical to those during the face-to-face consultation.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Elevated American Society of Anesthesiologists (ASA) score in each group
Time Frame: anesthesia consultation = 1 week to 3 months after inclusion
Yes/no for if score=3-4
anesthesia consultation = 1 week to 3 months after inclusion
Elevated American Society of Anesthesiologists (ASA) score in each group
Time Frame: pre-anesthetic visit = 9 days to 3 months+7 days after inclusion
Yes/no for if score=3-4
pre-anesthetic visit = 9 days to 3 months+7 days after inclusion
Difficulty in accessing airways each group
Time Frame: anesthesia consultation = 1 week to 3 months after inclusion
Yes/no for mouth opening ≥35 mm
anesthesia consultation = 1 week to 3 months after inclusion
Difficulty in accessing airways each group
Time Frame: pre-anesthetic visit = 9 days to 3 months+7 days after inclusion
Yes/no for mouth opening ≥35 mm
pre-anesthetic visit = 9 days to 3 months+7 days after inclusion
Medication conciliation performed during the anesthesia consultation each group
Time Frame: pre-anesthetic visit = 9 days to 3 months+7 days after inclusion
Yes/no: adaptations of selected therapies: anticoagulants, anti-aggregants, anti-hypertension, antidiabetics
pre-anesthetic visit = 9 days to 3 months+7 days after inclusion
Medication conciliation performed during the anesthesia consultation each group
Time Frame: anesthesia consultation = 1 week to 3 months after inclusion
Yes/no: adaptations of selected therapies: anticoagulants, anti-aggregants, anti-hypertension, antidiabetics
anesthesia consultation = 1 week to 3 months after inclusion
Difference between groups in composite score of above outcomes (elevated ASA score, difficulty accessing airways and medication conciliation)
Time Frame: pre-anesthetic visit = 9 days to 3 months+7 days after inclusion
Difference in number of yes/no answers at anesthesia consultation compared to pre- anesthetic visit
pre-anesthetic visit = 9 days to 3 months+7 days after inclusion
Difference between groups in composite score of above outcomes (elevated ASA score, difficulty accessing airways and medication conciliation)
Time Frame: anesthesia consultation = 1 week to 3 months after inclusion
Difference in number of yes/no answers at anesthesia consultation compared to pre- anesthetic visit
anesthesia consultation = 1 week to 3 months after inclusion

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of canceled surgeries in each group
Time Frame: Day 2 after pre-anesthetic visit
Yes/no surgery not performed on the scheduled day and / or postponed > 2 days
Day 2 after pre-anesthetic visit
Reason for cancellation of surgery
Time Frame: Day 2 after pre-anesthetic visit
Description noted in electronic clinical report form
Day 2 after pre-anesthetic visit
Number of delayed surgeries in each group
Time Frame: Day 2 after pre-anesthetic visit
Yes/no surgery not performed on the scheduled day and / or postponed ≤ 2 days
Day 2 after pre-anesthetic visit
Reason for delayed surgery
Time Frame: Day 2 after pre-anesthetic visit
Description noted in electronic clinical report form
Day 2 after pre-anesthetic visit
Complication rate in perioperative and immediate postoperative period
Time Frame: 2 days post-operatively
% patients with a complication
2 days post-operatively
Rate of anesthesia consultation rescheduling in each group
Time Frame: 2 days after pre-anesthetic visit
Number of consultations rescheduled
2 days after pre-anesthetic visit
Reason for rescheduling
Time Frame: 2 days after pre-anesthetic visit
Description noted in electronic clinical report form
2 days after pre-anesthetic visit
Global patient satisfaction
Time Frame: pre-anesthetic visit = 9 days to 3 months+7 days after inclusion
satisfaction on a visual analog scale 0-10
pre-anesthetic visit = 9 days to 3 months+7 days after inclusion
Satisfaction on the delivery of the information
Time Frame: pre-anesthetic visit = 9 days to 3 months+7 days after inclusion
6-item custom questionnaire completed on a Likert 0 - 5 scale for all patients plus 6 questions specific for control group and 7 for intervention group
pre-anesthetic visit = 9 days to 3 months+7 days after inclusion
Ecological impact of the consultation in each group
Time Frame: pre-anesthetic visit = 9 days to 3 months+7 days after inclusion
Carbon impact (CO2 generated) of number of km between the patient's home and the hospital
pre-anesthetic visit = 9 days to 3 months+7 days after inclusion
Economic impact of the consultation in each group
Time Frame: pre-anesthetic visit = 9 days to 3 months+7 days after inclusion
Cost in euros of cost of travel and time at work missed
pre-anesthetic visit = 9 days to 3 months+7 days after inclusion
Rate of presence of the usual treatment prescription
Time Frame: During the anesthesia consultation = 1 week to 3 months after inclusion
Yes/no
During the anesthesia consultation = 1 week to 3 months after inclusion
Rate of presence of the completed health questionnaire
Time Frame: During the anesthesia consultation = 1 week to 3 months after inclusion
Yes/no
During the anesthesia consultation = 1 week to 3 months after inclusion
Rate of presence of specialist consultation reports less than 1 year old
Time Frame: During the anesthesia consultation = 1 week to 3 months after inclusion
Yes/no
During the anesthesia consultation = 1 week to 3 months after inclusion

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Estelle Morau, CHU Nîmes

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 20, 2021

Primary Completion (Actual)

April 21, 2022

Study Completion (Actual)

April 21, 2022

Study Registration Dates

First Submitted

May 27, 2021

First Submitted That Met QC Criteria

June 3, 2021

First Posted (Actual)

June 10, 2021

Study Record Updates

Last Update Posted (Estimated)

December 22, 2025

Last Update Submitted That Met QC Criteria

December 16, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • NIMAO/2020-2/EM-01
  • 2021-A00311-40 (Other Identifier: ANSM)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Telemedicine

Clinical Trials on Remote anesthesia consultation

Subscribe